Abstract
摘要
相似文献
1
Clofibrate: a final verdict?
Lancet. 1978 Nov 25;2(8100):1131-2.
2
The clofibrate trial--the lipid hypothesis retested.氯贝丁酯试验——对脂质假说的重新检验
Med J Aust. 1979 Jun 2;1(11):490-1.
3
[Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].[氯贝丁酯衍生物的实际或声称风险及其被禁止的某些风险]
Nouv Presse Med. 1979 Mar 31;8(15):1223-5.
4
Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.胆固醇、氯贝丁酯与缺血性心脏病。相关的事实与情绪。
Cor Vasa. 1979;21(6):377-9.
5
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.一项使用氯贝丁酯进行缺血性心脏病一级预防的合作试验。主要研究者委员会的报告。
Br Heart J. 1978 Oct;40(10):1069-118. doi: 10.1136/hrt.40.10.1069.
6
Hypolipaemic drugs and coronary heart disease.降血脂药物与冠心病
J Clin Pathol Suppl (R Coll Pathol). 1975;9:106-14.
7
[Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Lakartidningen. 1974 Sep 4;71(36):3289-91.
8
[Study of clofibrate. The opinion of Prof. D. Kritchevsky].
Minerva Cardioangiol. 1980 Nov;28(11):759-60.
9
Clofibrate and niacin in coronary heart disease.氯贝丁酯与烟酸治疗冠心病
JAMA. 1975 Jan 27;231(4):360-81.
10
[Is hypolipemic treatment effective as a preventive measure?].
Przegl Lek. 1989;46(7):619-23.
引用本文的文献
1
Ethics of clinical trials -- the use of placebo.临床试验的伦理——安慰剂的使用。
Eur J Clin Pharmacol. 1979 Nov;16(5):295-7. doi: 10.1007/BF00605624.
Zotero 插件